Yield10 Bioscience's (YTEN) CEO Oliver Peoples on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 03/17/21
Yield10 Bioscience Announces Fourth Quarter and Full Year 2020 Financial ResultsGlobeNewsWire • 03/16/21
Yield10 Bioscience to Present at Maxim Group's 2021 Inaugural Emerging Growth Virtual ConferenceGlobeNewsWire • 03/11/21
Yield10 Bioscience to Announce Fourth Quarter and Full Year 2020 Financial Results and Host a Conference Call on Tuesday, March 16, 2021GlobeNewsWire • 03/09/21
Yield10 Bioscience to Present at Bank of America 2021 Virtual Global Agriculture & Materials Conference on March 4, 2021GlobeNewsWire • 03/01/21
4 Agriculture Operations Stocks Countering Challenges Facing the IndustryZacks Investment Research • 01/19/21
Yield10 Bioscience Announces Achievement of Proof-of-Concept Milestone for Producing PHA Bioplastic in Field Grown Camelina PlantsGlobeNewsWire • 01/19/21
Yield10 Bioscience Researcher Dr. Meghna Malik to Present at the 4th CRISPR AgBio Congress 2020 Virtual EventGlobeNewsWire • 12/02/20
Yield10 Bioscience, Inc. (YTEN) CEO Oliver Peoples on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/13/20
Yield10 Bioscience Announces Collaboration with Rothamsted Research to Develop Advanced Technology for Producing Omega-3 Nutritional Oils in CamelinaGlobeNewsWire • 11/12/20
Yield10 Bioscience to Announce Third Quarter 2020 Financial Results and Host a Conference Call on Thursday, November 12, 2020GlobeNewsWire • 11/05/20
Yield10 Bioscience Announces Start of Field Tests of Winter Camelina VarietiesGlobeNewsWire • 10/28/20
Yield10 Bioscience Announces Completion of Harvesting for 2020 Field Test Program to Evaluate Novel Yield and Compositional Traits in Camelina and CanolaGlobeNewsWire • 10/01/20
Yield10 Bioscience Announces Participation at The H.C. Wainwright 22nd Annual Global Investment Conference on September 14-16, 2020 (Virtual Conference)GlobeNewsWire • 09/09/20
4 Agriculture Operations Stocks Set to Dodge Near-Term Industry ChallengesZacks Investment Research • 09/03/20
Yield10 Bioscience Announces Closing of $4.0 Million Public Offering, Including Exercise of the Over-Allotment Option, and Concurrent $1.7 Million Private PlacementGlobeNewsWire • 08/26/20
Yield10 Bioscience Announces Pricing of $5.2 Million Public Offering and Concurrent Private PlacementGlobeNewsWire • 08/23/20
Yield10 Bioscience Announces Proposed Public Offering of Common Stock and Concurrent Private PlacementGlobeNewsWire • 08/21/20
Yield10 Bioscience Obtains Positive Response from USDA-APHIS on Regulated Status of its CRISPR Genome-Edited C3007 Trait in Canola; Plans U.S. Field Tests for 2021GlobeNewsWire • 08/17/20
Yield10 Bioscience, Inc. (YTEN) CEO Oliver Peoples on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/12/20